Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)
Financial Results:
Biocon Ltd reported Revenues for Q2FY25 of ₹3,590.00 Crores up from ₹3,462.00 Crore year on year, a rise of 3.7%.
Total Expenses for Q2FY25 of ₹3,551.00 Crores up from ₹3,382.00 Crores year on year, a rise of 5.0%.
Consolidated Net Profit of ₹27.00 Crores down 84.39% from ₹173.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹0.13, from ₹1.05 in the same quarter of the previous year.